Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON26235
NL-OMON26235
Recruiting
N/A

Effect of botulinum toxin (BoNT-A) injections on intrinsic and reflexive contributions to ankle joint resistance for patients with spasticity

Sint Maartenskliniek Research0 sites10 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsSpinal Cord Injury and Stroke

Overview

Phase
N/A
Intervention
Not specified
Conditions
Spinal Cord Injury and Stroke
Sponsor
Sint Maartenskliniek Research
Enrollment
10
Status
Recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Sponsor
Sint Maartenskliniek Research

Eligibility Criteria

Inclusion Criteria

  • •A minimum of 6 months post\-lesion/post\-stroke to ensure that the subject has a stable neurological condition, without clinical alterations.
  • •\- Age 18 years or older at the time of the study
  • •\- Spasticity of any/all of the m. triceps surae, i.e. have a MAS/Tardieu score \= 1
  • •\- Have an ankle joint range of motion (ROM) of at least 20°in the sagittal plane
  • •\- Ability to make a transfer on to the Achilles (medical device)
  • •\- Current treatment of any/all of the m. triceps surae with BoNT\-A for spasticity reduction

Exclusion Criteria

  • •\- Have a MAS score of 4
  • •\- Receive BoNT\-A combined with other therapies aimed at reducing spasticity

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not Yet Recruiting
N/A
Effect of botulinum toxin (BoNT-A) injections on intrinsic and reflexive contributions to ankle joint resistance for patients with spasticity.
NL-OMON48057Stichting Sint Maartenskliniek10
Active, Not Recruiting
N/A
The effect of botulinum toxin type A injections in the m. rectus femoris in stroke patients presenting with a stiff knee gait. - Botulinum toxin type A injections in stiff knee gaitStroke patients with stiff knee gait. Stiff knee gait is characterized as a diminished knee flexion during swing phase of gait. It is common in stroke patients.
EUCTR2009-018226-29-NL26
Completed
Phase 3
The effect of botulinum toxin type A injections in the m. rectus femoris in stroke patients presenting with stiff knee gaitstiff knee gaitstiff-legged knee1000796310057166
NL-OMON39359Revalidatiecentrum Het Roessingh26
Completed
Phase 2
botulinum toxin type A and diabetic neuropathyDiabeticr polyneuropathy.Type 2 diabetes mellitus with diabetic polyneuropathyE10.42
IRCT20190129042540N1Rafsanjan University of Medical Sciences50
Not Yet Recruiting
N/A
The effect of botulinum toxin-A(BTX-A) injection for equinovarus deformity in children with unilateral cerebral palsy.Diseases of the nervous system
KCT0000530Yonsei University Health System, Severance Hospital30